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ine.de (O. Holz).Summary Currently no published data are available concerning the comparability
of different types of NO analysers, making inter-laboratory comparisons difficult. In
two sets of experiments we compared 4 and 5 NO analysers, respectively, from 3
different manufacturers using different calibration regimes: calibration with (1) a
separate recommended calibration gas for each analyser, (2) a single low
concentration for all (394 ppb), and (3) a single high concentration (12.8 ppm). We
measured three subjects with known low (L), moderate (M) and high (H) bronchial
exhaled nitric oxide concentrations as well as standard gases (SG). In the first set of
experiments, calibration regime 1 resulted in the largest differences between
analysers (coefficient of variation (CV) for L, M, H, SG: 0.42, 0.22, 0.20, 0.14). The
lowest CV between analysers was observed after calibration 2 (0.34, 0.19, 0.12,
0.02). Very similar results were obtained in the second set of comparisons. Thus,
differences between analysers existed, but were mainly due to differences in
recommended calibration gases/procedures. Only a small part was explainable by
deviations from target flow. These differences need to be taken into account when
comparing data between laboratories or replacing the calibration gas of an analyser,
as well as for the establishment and interpretation of normal values.
& 2004 Elsevier Ltd. All rights reserved.Introduction
The measurement of exhaled nitric oxide (eNO) is
increasingly used in clinical settings to monitor
airway inflammation and to support the diagnosis ofElsevier Ltd. All rights reserv
2 601 269;
earch.de,diseases such as asthma or primary cilia dyskine-
sia.1–3 Though the distribution of eNO values clearly
differs between airway diseases, normal values do
not exist. They are, however, increasingly de-
manded, though it is not known, for example,
how comparable data obtained with different
analysers actually are.
It was therefore the aim of this study to compare
NO analysers from different manufacturers under
different setup and calibration regimes. At present,ed.
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K.C. Mu¨ller et al.632NO analysers from 4 main manufacturers seem to
be most commonly used. Despite the fact, however,
that they all use the chemiluminescence method
for detection, there are a number of factors
influencing the readings, such as the basic setup,
measuring chamber and sampling tube design, the
way expiratory flow is controlled or measured,
sensitivity to ambient conditions, or differences in
calibration. To account for these factors as much as
possible we compared NO analysers from 3 differ-
ent manufacturers under the same or similar
ambient conditions, checked flow rate by the use
of a bell spirometer, and studied the effect of
calibration by comparing the analysers using
different calibration regimes. Comparisons were
performed by measurements in 3 subjects (1
healthy, 1 rhinitic, 1 mild asthmatic) with known
stable eNO values, as well as by NO standard gases.
In a first set of measurements we compared 4, and
in a second set 5 NO analysers.Material and methods
Analysers
Two NIOXs (NIOX1, NIOX2) (Aerocrine, Solna,
Sweden) analysers used in research mode were
constantly running, while two Sievers NOAs280
(NOA1, NOA2) (Boulder, USA) and one ECO medicss
(ECOM) (ECO PHYSICS, Duernten, Switzerland) were
started at least 3 h prior to calibration and
measurements. NIOX analysers were used with the
calibration gas recommended by Aerocrines
(198 ppb, accuracy 5%, Hoek Loos Specialty Gases,
Amsterdam, The Netherlands). ECO medics recom-
mends and delivers its analyser with a 12.8 ppm
standard gas (accuracy not available, certified
grade, SIP Analytical Ltd., Kent, UK). This gas was
diluted within the analyser about 17-fold, resulting
in a calibration with approximately 750 ppb. The
NOA1 was calibrated with 394 ppb (accuracy 5%,
Messer Griesheim (MG), Krefeld, Germany) and the
NOA2 was calibrated with 450 ppb (accuracy not
available, Westfalen, Osnabru¨ck, Germany) in the
first set of comparisons and with a 417 ppb gas
(accuracy 5%, MG) in the second set.
The NIOX analysers had a built-in NO trap for zero
point calibration, while an external zero gas (SIP
Analytical Ltd.) was used for the ECOM and a zero
filter (Sievers, FMI, Seeheim, Germany) for both
NOA1 and NOA2.
All analysers except the NOA2 were situated in
one room to ensure equal ambient conditions;
the NOA2 was permanently used for clinicalmeasurements and could not be moved but ambient
conditions were similar. The standard gases (SG)
used for testing, in addition to subjects, had
411 ppb (accuracy 5%, MG), 394 ppb (MG, also used
for calibration), and 476 ppb (accuracy 5%, MG).Expiratory flow rate
The NIOX had an internal flow restrictor maintain-
ing a flow of 50mL/s as long as subjects kept
sufficient pressure. For both NOA we used a
custom-made system including a number of resis-
tors and a computer program to achieve a visual
feedback for the subjects to expire at a pressure of
20mbar. For all resistors, non-linear flow–pressure
curves had been assessed using a calibrated bell
spirometer (VOLUTEST, Mijnhardt, Zeist, The Neth-
erlands) as flow integrator, so that deviations from
the target pressure/flow could be taken into
account. This setup was used to correct for
deviations from target flow of eNO in each subject,
using a 2-parameter transfer model of flow
dependence (NO=concairway wall(1exp(transfer
factor/flow rate), e.g. Jo¨rres1).
The ECOM also used a flow resistance. The actual
flow rate was measured by an ultrasonic sensor,
which was calibrated according to recommenda-
tions prior to measurements. The accuracy of flows
through all systems (2 NIOX flow restrictors, 1 NOA
resistor, ECOM flow sensor) was checked using a
calibrated bell spirometer by integrating flow over
time at 20mbar.Calibration regimes
Handling of calibration gases was performed ac-
cording to the manufacturers’ instructions. We
carefully rinsed pressure valves after attachment
to bottles and avoided sudden pressure changes to
minimise the risk of contamination with air, which
can result in the slow decay of the NO in calibration
flasks.
Calibration 1: Each analyser was calibrated prior
to comparisons with the gas either provided by or in
a concentration recommended by the respective
manufacturer as described above.
Calibration 2: All analysers were calibrated with
the same calibration gas (394 ppb, MG). This gas
with this concentration was not recommended by
Aerocrine, but could be used in research mode. The
ECOM needed a concentration 41 ppm for calibra-
tion; therefore, this calibration required a special
method provided by the manufacturer.
Calibration 3: Analogous to calibration 2, but a
12.8 ppm gas (SIP) was used. Due to internal
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mately 750 ppb in the ECOM. Both NOA analysers
were calibrated by indicating that this calibration
should be used for measurements in both the ppb
and ppm range.Study design
One healthy female with known low eNO value
(mean over study period: 11 ppb), one male subject
with rhinitis tested out of season (32 ppb) and one
male subject with a history of mild asthma in stable
condition without medication (50 ppb) were chosen
for this study. Subjects were experienced in
performing NO measurements.
The first set of measurements (comparison 1) was
performed on 3 days within a 4 day period to avoid
major changes of NO values (NOA1/NOA2, NIOX1,
ECOM). On each consecutive day one of the 3
calibration regimes was used. To check for a drift of
analysers, we additionally performed the measure-
ments of calibration regime 2 at midday and in the
afternoon.
On each day, NO measurements of the 3 subjects
and standard gases were done in random order.
Each subject performed at least 3 measurements
and NO levels were determined from mean values
of valid plateaus according to the published guide-
lines.4 The flow rate indicated by the respective
analyser was always within 5% of 50mL/s. Subjects
inhaled NO-free air from the NIOX and ECOM built-
in NO scrubbers, while NOA measurements were
performed by inhaling ambient air. Ambient air NO
concentrations as detected by all analysers were
always below 3 ppb and NOA values did not differ
when NO-free air (supplied by the ECOM NO-
scrubber) was inhaled. Standard gases were mea-
sured by leading the gas through an open tube
under low pressure, with the input nozzle of the
analyser actively sampling from this flow. A custom-
made adapter was used for the NIOX and sampling
was started manually.
The second set of experiments (comparison 2)
was performed about 8 weeks after the first one, to
verify the differences observed in comparison 1 and
because an additional NIOX analyser was available
at this time. Measurements were performed as
described above in the same 3 subjects using
calibration regimes 1 and 2. Based on the results
of comparison 1 we refrained from repeating
calibration regime 3. Calibration gases from com-
parison 1 were used again, except for the NOA2. In
calibration regime 1, both NIOX analysers were
calibrated with 198 ppb. All measurements of
comparison 2 were repeated the next day.Data analysis
To quantify the differences between analysers in an
illustrative way, standard deviations (SD) and
coefficients of variation (CV) were evaluated
instead of Bland–Altman-like plots which did not
seem to offer an advantage. Friedmans ANOVA was
used to compare CV and SD between the different
calibration regimes, and the Wilcoxon matched-
pairs signed-ranks test for comparisons between
single conditions. A P value of o0.05 was con-
sidered statistically significant.Results
Tables 1 and 2 summarise the data for both
comparisons. Data of comparison 2 in Fig. 1 were
normalised by defining the mean concentration over
all analysers as 100%. In both sets of experiments the
variability (CV) between analysers was significantly
different (Friedmans ANOVA, Po0:05 each), and the
lowest variability between analysers was observed
when they were calibrated with the same low
concentration gas (394ppb) (compared to calibration
with separate gases P ¼ 0:04 in comparison 1 and
P ¼ 0:07 in comparison 2; Wilcoxon test). In line with
this, SD as a measure of variation between analysers
yielded similar results (ANOVA, comparison 1: P ¼
0:007; comparison 2: P ¼ 0:045; post hoc Wilcoxon:
P ¼ 0:04 and 0.07, respectively).
After sufficient warm-up of all analysers we
found no indication for a major drift of measure-
ments over the day, the overall median (quartiles)
of the differences between the two time points
being 0.0 (4.2; 1.5) ppb (3 subjects and 2
standard gases 4 analysers, n ¼ 20). The coeffi-
cient of reliability for these repeated comparison
between analysers was 0.997.
The mean7SD nominal flow rate indicated by the
analysers was 50.271.4, 50.571.3mL/s for the
NOA1/NOA2, 5070mL/s for both NIOX1/NIOX2,
and 49.671.7mL/s for the ECOM. For NOA1/NOA2
and NIOX1/NIOX2 analysers, actual flow rates as
determined by the bell spirometer were close to
nominal values: NOA1/NOA2: 47.470.5mL/s
(+2.5mL/s sample tube flow=49.9mL/s); NIOX1:
46.070.7 (þ4:1mL=s ¼ 50:1mL=s); NIOX2:
44.071.8mL/s (þ4:1mL=s ¼ 48:1mL=s). Using a
calibrated flow of 47.971.0mL/s, the ECOM
showed 43.474.0mL/s. Based on the data from
the NOA1 and the custom-made resistors and
software, we found that a deviation from target
flow by 4mL/s would explain changes in NO values
of71, 72, and73 ppb in subjects L, M, and H.
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Table 1 NO values (ppb) in comparison 1 using 4 analysers.
Calibration ECOM NIOX1 NOA1 NOA2 Mean SD CV
Subject
L 5.4 11.4 16.7 10.9 11.1 4.6 0.415
M 1 23.6 33.9 39.6 28.8 31.5 6.9 0.219
H 37.6 56.0 57.7 44.8 49.0 9.5 0.195
Standard gas
SG 411 ppb 330.0 387.0 440.0 340.0 374.3 50.4 0.135
SG 394 ppb 305.0 377.0 405.0 315.0 350.5 48.3 0.138
Subject
L 6.5 9.5 11.8 15.2 10.7 3.7 0.343
M 2 22.3 30.5 33.0 35.3 30.3 5.6 0.186
H 44.5 53.8 59.6 54.7 53.2 6.3 0.119
Standard gas
SG 411 ppb 440.0 425.0 435.0 445.0 436.3 8.5 0.020
SG 394 ppb 405.0 395.0 400.0 410.0 402.5 6.5 0.016
Subject
L 5.1 4.1 13.0 9.0 7.8 4.0 0.518
M 3 20.4 23.5 34.5 31.3 27.4 6.6 0.240
H 37.4 46.1 55.1 49.9 47.1 7.4 0.158
Standard gas
SG 411 ppb 330.0 356.0 385.0 370.0 360.3 23.4 0.065
SG 394 ppb 305.0 328.0 355.0 345.0 333.3 21.9 0.066
Calibration 1: each analyser calibrated with separate recommended calibration gas.
Calibration 2: each analyser calibrated with the same low concentration gas (394 ppb) Calibration 3: each analyser calibrated
with the same high concentration gas (12.8 ppm, the ECOM dilutes this gas internally to approx. 750 ppb). NO values represent
the mean of 3 measurements with valid plateau levels.
K.C. Mu¨ller et al.634Discussion
Our data suggest that differences in measured
values between NO analysers of different manu-
facturers exist, as exemplified in a sample of five
analysers from three companies. The major factor
responsible for these differences appeared to
originate from differences in calibration gases and
procedures. Only a small part seemed to be
explainable by deviations from the target flow rate
of 50mL/s.
For each analyser tested the repeated NO
measurements of stable subjects within 8 weeks
yielded very similar results (Table 1 vs. Table 2), in
line with the known reproducibility of NO values.
This was also true for the two measurements
performed on 1 day which were performed to
assess instrument drift. It is known that especially
the NOA and ECOM require sufficient warm-up time
to avoid drifts in measured values over the day.
In both calibration regimes the pattern of
differences between analysers was very similar
(Fig. 1). The smallest differences between analy-
sers were obtained when comparing standard gases
in the range of 400 ppb. The comparison of
subjects’ NO values resulted in larger CV values,which were inversely related to mean eNO: the
lower mean eNO, the higher the CV between
analysers. Conversely, comparing SD values between
analysers we found the lowest SD in the subject with
the lowest NO value (L) and the largest SD when
standard gases were compared, however, the ratio
between both SD values was smaller than that
between corresponding mean values (Tables 1 and
2), resulting in the difference of CV values. This
demonstrates that SD values between analysers
were neither constant nor proportional to the mean
value. Although standard gases were in the con-
centration range of calibration gases, in contrast to
subjects, it is unlikely, that the relatively greater
differences between analysers as observed in
subjects were due to differences in zero point
calibration. Ambient air NO levels were always very
low, so that potential differences in the efficacy of
NO-scrubbers could be neglected. Furthermore,
only a minor part of the increase in variability in
subjects compared to standard gases could be
attributed to deviations from target flow. The fact
that human breath is saturated with water vapor
also needs to be taken into account when inter-
preting the differences between measurements of
standard gases and subjects. Therefore differences
ARTICLE IN PRESS
Figure 1 Comparison of 5 NO-analysers. Data were normalized to the overall mean value of all analysers to allow better
comparability. NO values of 2 measurements on consecutive days are shown. Left: data after calibration of analysers
with separate calibration gases (both NIOX were calibrated with a single gas, 198 ppb; no data available for day 2 for
NIOX1 due to technical reasons). Right: data after calibration with a common single gas (394 ppb). Top to bottom:
Measurement of standard gas (476 ppb), subject with high (H, overall mean 51 ppb), medium (M, 32 ppb) and low (L,
11 ppb) exhaled NO level.
Table 2 NO values (ppb) in comparison 2 using 5 analysers.
Calibration Day ECOM NIOX1 NIOX2 NOA1 NOA2 Mean SD CV
Subject
L 5.3 12.3 10.3 8.4 10.9 9.4 2.7 0.289
M 22.5 36.2 36.0 27.7 30.9 30.7 5.8 0.189
H 1 35.9 62.1 56.7 52.6 51.2 51.7 9.8 0.189
Standard gas
SG 476 ppb 1 360 385 395 475 450 413.0 47.8 0.116
Subject
L 6.6 18.2 11.5 13.4 11.5 12.2 4.2 0.340
M 20.4 44.7 33.8 29.9 32.9 32.3 8.7 0.269
H 2 38.9 66.5 56.5 52.3 47.8 52.4 10.2 0.195
Standard gas
SG 476 ppb 370 nd 410 460 457 424.3 42.8 0.101
Subject
L 3.5 11.6 10.3 8.8 12.2 9.3 3.5 0.372
M 1 24.3 31.9 31.7 26.6 32.9 29.5 3.8 0.129
H 39.5 51.9 55.2 49.6 59.6 51.2 7.5 0.147
Standard gas
SG 476 ppb 2 445 475 475 470 473 467.6 12.8 0.027
Subject
L 10.2 14.2 14.8 11.0 14.0 12.9 2.1 0.163
M 2 28.8 36.6 33.9 30.0 33.8 32.6 3.2 0.097
H 43.8 53.5 51.2 45.8 52.2 49.3 4.2 0.086
Standard gas
SG 476 ppb 442 465 475 470 465 463.4 12.7 0.027
Calibration 1: each analyser calibrated with separate recommended calibration gas.
Calibration 2: each analyser calibrated with the same low concentration gas (394 ppb).
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K.C. Mu¨ller et al.636between analysers regarding the efficacy or meth-
od of water vapor removal could have contributed
to variability and particularly the differences
between measurements in subjects and those of
standard gases.
The reduction of differences between NOA1 and
NOA2 in comparison 2 was most likely due to the
calibration gas used for the NOA2 in comparison 1.
Based on the findings obtained with other gases
from different manufacturers, there was evidence
that the calibration gas had a concentration
different from that indicated. It was therefore
replaced in comparison 2. This underlines the need
to be critical regarding calibration gases and to be
able to compare with independent standards,
whenever possible. The remaining differences
between NOA analysers in comparison 2 could then
be attributed only to ambient conditions, as the
NOA2 was located in a slightly cooler room, or to
physical and electronic factors such as detection
tube temperature and vacuum. Similar differences
were also observed between NIOX analysers in
comparison 2, though they were calibrated with
the same gas (Table 2). We would like to mention
that on day 2 of comparison 2 (Table 2), NIOX1 did
not measure correctly and needed repair. Values for
the subjects were much higher compared to those
the day before and no value could be obtained for
the standard gas. These values were therefore
omitted from the analysis.
There was a trend towards lower values detected
by the ECOM. The reason for this is not clear but
the phenomenon has also been observed by others.5
Using the bell spirometer as standard, we con-
cluded that in our setup the ECOM measured flow
rate too low, which would result in a higher flow
rate during measurements of subjects. However,
the deviation of about 4mL/s from the required
flow 50mL/s explained only a small part of the
differences. In addition, relatively low values were
also observed with the standard gases. The ECOM
used a gas mixture of approximately 700–800 ppb
for internal calibration, which was higher than
concentrations used by the NIOX and NOA. The
factors underlying the reduction in measured NO
values in the ECOM are unknown to us.
Though the use of the 12.8 ppm gas for calibra-
tion in comparison 1 resulted in a lower variability
(CV) between analysers, absolute values of mea-
surements were quite different within analysers,
except in the ECOM, for which this was the
recommended gas. While the NOA could be
calibrated with gases in the ppm range, this was
not recommended for the NIOX, and the high
concentration gas might have led to the relatively
large deviations (Table 1). Owing to this, the12.8 ppm calibration regime was omitted in com-
parison 2.
We would like to point out that on the basis of
our results it is not possible to rate analysers in
performance or reliability or to conclude that one
analyser was measuring correctly and another not.
We did not have the means to chemically analyse
calibration gases, and a reference sample is
currently not commercially available. Thus one
has to rely on data provided by gas suppliers and
the ‘‘true’’ NO values of gases as well as exhaled air
are not known.
From our results one might conclude that
analysers from different manufacturers show a
sufficient comparability for practical purposes,
provided proper calibration is performed. However,
analysers in different laboratories will inevitably
use different calibration gases and/or procedures.
Therefore the variability observed in this study
needs to be considered. In a subject with a mean
exhaled NO level of about 50 ppb we observed a
maximum deviation of 420 ppb between analyser
setups (Table 2, calibration 1). In our view,
deviations of this magnitude cannot be neglected.
Such differences have also to be taken into account
in the establishment and interpretation of normal
values. In addition, they might affect longitudinal
studies whose duration exceeds the shelf-life of
calibration gases. For the analysers tested in this
study only one concentration gas was needed, in
addition to zero air. In case of calibration gas decay
(due to improper handling in connecting gas
tubings), there is a high risk for incorrect measure-
ments, as this slow decay can proceed unnoticed
for a long period of time. Despite the increase in
costs, our results therefore suggest the introduc-
tion of an independent standard gas, which is used
for frequent tests of analyser setup and the validity
of calibration. Noteworthy enough, this is already
suggested in guidelines.4 An alternative, currently
not available but extremely desirable, would be
widely available calibrated small stable reference
gas samples to check analysers and to improve
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